Iceland
Tuberculosis profile
Population  2012 <1 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) <0.01 (<0.01–<0.01) 0.27 (0.27–0.27)
Mortality (HIV+TB only) <0.01 (<0.01–<0.01) 0.03 (0.02–0.04)
Prevalence  (includes HIV+TB) 0.014 (<0.01–0.028) 4.3 (1.5–8.5)
Incidence  (includes HIV+TB) 0.012 (0.01–0.013) 3.5 (3.1–4)
Incidence (HIV+TB only) <0.01 (<0.01–<0.01) 0.24 (0.21–0.28)
Case detection, all forms (%) 87 (77–99)    
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive 2 (20) Relapse 0 (0)
Smear-negative 2 (20) Treatment after failure 0 (0)
Smear-unknown / not done 3 (30) Treatment after default 0 (0)
Extrapulmonary 3 (30) Other 1 (100)
Other 0 (0)      
Total new 10   Total retreatment 1  
           
Other (history unknown) 0        
Total new and relapse 10   Total cases notified 11  
New cases Smear-positive Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio 1.0 0.7  
Age < 15 0 0 0
Laboratories 2012
Is second-line drug susceptibility testing available? Yes, outside
country
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive     Is rifampicin used
throughout treatment for
new patients?
Yes
New smear-negative/extrapulmonary 89  
Retreatment 100  
TB/HIV 2012 Number (%)
TB patients with known HIV status 11 (100)
HIV-positive TB patients 0 (0)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT) 0  
HIV-positive TB patients on antiretroviral therapy (ART) 0  
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 0 (0–60) 100 (2.5–100)
MDR-TB cases among notified pulmonary
TB cases
0 (0–4) 1 (0–1)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB 4 (100%) 1 (100%) 5
Laboratory-confirmed MDR-TB cases 0 1 1
Patients started on MDR-TB treatment     1
Financing TB control 2013
National TB programme budget (US$ millions) 1.4
***
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __
Retreatment

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-23 Data: www.who.int/tb/data